Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of the Effects of Bone Marrow Biopsy Decalcification Methods on Histopathological Examination

골수생검조직의 조직병리검사에서 탈회방법에 따른 결과 분석

  • Park, Ji Young (Department of Pathology, Yonsei University Severance Hospital) ;
  • Han, Kyung Hee (Department of Pathology, Yonsei University Severance Hospital)
  • 박지영 (연세대학교 세브란스병원 병리과) ;
  • 한경희 (연세대학교 세브란스병원 병리과)
  • Received : 2016.09.05
  • Accepted : 2016.10.05
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Decalcification is routinely performed to obtain a pathological diagnosis using bone marrow biopsy. During the decalcification process using a conventional acidic solution, such as HCl, the antigenicity of tissue is damaged. Especially DNA and RNA in the bone marrow are impaired. Hence, there is the need for a standardized decalcification protocol that preserves the antigenicity of tissue. To this end, we compared the effects of two commonly used decalcifiers: Commercial decalcifier (Calcl-Clear Rapid, HCl) and the EDTA (12.5%, pH 7.0). Bone marrow biopsies sampled from 71 patients were decalcified in accordance with the protocols of respective groups-HCI versus EDTA. The differences of decalcification protocols were analyzed with respect to Hematoxylin & Eosin staining, Gomori'sreticulum staining, and immunohistochemical staining and molecular analysis. Immunohistochemical staining used Ki-67, CD20 and CD138 as primary antibodies and molecular analysis was conducted through the DNA concentration analysis, in situ hybridization (ISH) and immunoglobulin heavy chain (IGH) gene rearrangement. On the routine histopathology analysis, there was no difference between HCl and EDTA. Moreover, in case of immunohistochemical staining, the cytoplasmic membrane or cytoplasmic CD markers was well preserved. However, nuclear proteins, such as Ki-67, were stained with low quality. Conversely, according to the molecular analysis, the EDTA protocol preserved the DNA and RNA compared with the HCI. The differences of DNA quantity and quality were statistically significant between protocols of HCl and EDTA. We used 38 cases in HCl and 12 cases in EDTA. Consequently, the EDTA protocol maintains the antigenicity of the protein on tissue and is acceptable for examination with molecular base analysis. Decalcification of bone marrow biopsy by EDTA is highly recommended for the examination of immunohistochemical staining and molecular analysis.

탈회방법은 골수조직의 병리학적 진단을 위해서 항상 시행되는 과정이다. HCl 탈회용액과 같이 주로 사용하고 있는 산성용액은 탈회과정 동안에 조직내의 항원성에 손상을 입힌다. 특히, 골수조직 내의 RNA나 DNA에 심하게 손상을 준다. 따라서 조직의 항원성을 보존하기 위한 표준화된 탈회방법이 필요하다. 본 연구는 일반적으로 가장 많이 사용되는 HCl 기반의 상품화된 탈회용액과 직접 제조한 EDTA 탈회용액이 골수조직의 탈회과정에 어떤 영향을 미치는지 분석하였다. 환자로부터 채취된 73예의 골수생검조직을 HCl 탈회와 EDTA 탈회의 두 그룹으로 나누어 탈회과정을 진행하였다. 골수생검조직의 탈회과정 후 결과의 차이는 hematoxylin & eosin 염색과 reticulum 염색, Ki-67, CD20, CD138의 항체를 이용한 면역조직화학염색, DNA 추출 및 분석, in situ hybridization, IGH gene rearrangement 와 같은 분자병리검사를 시행하여 분석하였다. 일반적인 염색과 특수염색에서는 두 탈회용액간의 차이는 없었다. 또한 세포증식 표지자와 같은 세포막 혹은 세포질에서 발현되는 항체는 탈회용액간의 차이 없이 잘 염색되었다. 반면 HCl 탈회 용액에 처리한 후 핵 내 단백질인 Ki-67의 염색상은 현저히 불량한 것으로 관찰되었다. HCl 탈회용액과 비교하여 EDTA 탈회용액에서의 골수생검조직 내의 DNA와 RNA가 잘 보존되었음을 다양한 분자병리검사를 통해 확인할 수 있었다. 특히 HCl 탈회용액에 처리한 28예와 EDTA 탈회용액에 처리한 12예의 DNA의 순도와 농도을 비교한 결과 통계학적으로 유의한 수준으로 차이가 있음을 확인하였다. 이로써 EDTA 탈회용액이 조직 내의 항원성을 잘 유지시키며, 면역조직화학염색과 분자병리검사에 적합한 방법임을 확인 할 수 있었다.

Keywords

References

  1. Choi MS, Lee HS, Kwon HC, Bae MH, Ko YH, Kim HJ, et al. Optimal fixation and decalcification methods for bone marrow biopsy. Korean J Clin Lab Sci. 2015;47(4):243-250. http://dx.doi.org/10.15324/kjcls.2015.47.4.243.
  2. Sarsfield P, Wickham CL, Joyner MV, Ellard S, Jones DB, Wilkins BS. Formic acid decalcification of bone marrow trephines degrades DNA: alternative use of EDTA allows the amplification and sequencing of relatively long PCR products. Mol Pathol. 2000;53:336-337. https://doi.org/10.1136/mp.53.6.336
  3. Dimenstein IB. Bone grossing techniques: helpful hints and procedures. Ann Diagn pathol. 2008;12:191-198. https://doi.org/10.1016/j.anndiagpath.2007.06.004
  4. Quintanilla-Martinez L, Tinguely M, Bonzheim I, Fend F. Bone marrow biopsy: processing and use of molecular techniques. Pathologe. 2012;33(6):481-489. https://doi.org/10.1007/s00292-012-1647-z
  5. Choi SE, Hong SW, Yoon SO. Proposal of an appropriate decalcification method of bone marrow biopsy specimens in the era of expanding genetic molecular study. J Pathol Transl Med. 2015;49:236-242. https://doi.org/10.4132/jptm.2015.03.16
  6. Erber WN, Asbahr HD, Phelps PN. In situ hybridization of immunoglobulin light chain Mrna on bone marrow trephines using biotinylated probes and the APPAAP. Pathology. 1993;25(1):63-67. https://doi.org/10.3109/00313029309068904
  7. Alers JC, Krijtenburg PJ, Vissers KJ, Dekken HV. Effect of bone decalcification procedures on DNA in situ hybridization and comparative genomic hybridization: EDTA is highly preferable to a routinely used acid decalcifier. J Histochem Cytochem. 1999;47(5):703-709. https://doi.org/10.1177/002215549904700512
  8. Singh VM, Salunga RC, Huang VJ, Tran Y, Erlander M, Plumlee P, et al. Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid(DNA and RNA) recovered from bone biopsies. Ann Diagn Pathol. 2013; 17:322-326. http://dx.doi.org/10.1016/ j.anndiagpath.2013.02.001.
  9. Sandberg Y, Van Gastel-Mol EJ, Verhaaf B, Lam KH, Van dongen JJM, Langerak AW. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace southern blot analysis in routine clonality diagnostics. J Mol Diag. 2005;7(4):495-503. http://dx.doi.org/10.1016/S1525-1578(10)60580-6.
  10. Castania VA, Silveira JW, Issy AC, Pitol DL, Castania ML, Neto AD, et al. Advantage of a combined method of decalcification compared to EDTA. Micro Res Tech. 2015;78:111-118. 10.1002/jemt.22451.
  11. Haiyan H, Weijun F, Hua J, Juan D, Lili Z, Chunyang Z, et al. The clinical characteristics and prognosis of IGH deletion in multiple myeloma. Leukemia Research. 2015;39:515-519. http://dx.doi.org/10.1016/j.leukres.2015.02.010.